Table 2.
Performance measures of regression coefficients after MI of covariates and PACQ score subcomponents in the treatment domain: MAR mechanism.
Proportion missing | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3% | 10% | 40% | |||||||||||
Effect | True esta | Bias | Model-based SE | Emp SEb | MSEc | Bias | Model-based SE | Emp SE | MSE | Bias | Model-based SE | Emp SE | MSE |
PAQC score intercept 1 | −7.825 | 0.018 | 0.015 | 0.017 | 0.005 | 0.021 | 0.023 | 0.024 | 0.001 | 0.022 | 0.036 | 0.036 | 0.002 |
PAQC score intercept 2 | −2.253 | −0.616 | 0.030 | 0.030 | 0.380 | −0.707 | 0.449 | 0.450 | 0.701 | −0.739 | 0.153 | 0.154 | 0.569 |
PAQC score intercept 3 | −1.189 | −0.327 | 0.080 | 0.080 | 0.113 | −0.375 | 0.319 | 0.321 | 0.242 | −0.392 | 0.414 | 0.414 | 0.325 |
PAQC score intercept 4 | 0.083 | −0.241 | 0.582 | 0.583 | 0.400 | −0.277 | 0.186 | 0.188 | 0.111 | −0.289 | 0.142 | 0.143 | 0.104 |
PAQC score intercept 5 | 1.371 | −0.264 | 0.237 | 0.237 | 0.126 | −0.303 | 0.373 | 0.374 | 0.231 | −0.317 | 0.249 | 0.249 | 0.162 |
PAQC score intercept 6 | 2.246 | −0.041 | 0.131 | 0.135 | 0.020 | −0.047 | 0.203 | 0.203 | 0.043 | −0.049 | 0.229 | 0.228 | 0.055 |
Age-group:12-59 | 0.154 | 0.038 | 0.083 | 0.088 | 0.008 | 0.044 | 0.147 | 0.148 | 0.023 | 0.046 | 0.170 | 0.172 | 0.032 |
Child sex: males | −0.046 | −0.027 | 0.216 | 0.216 | 0.047 | −0.031 | 0.259 | 0.260 | 0.068 | −0.032 | 0.276 | 0.277 | 0.078 |
Comorbidities: 0 | 0.474 | −0.130 | 0.228 | 0.230 | 0.069 | −0.149 | 0.014 | 0.015 | 0.022 | −0.156 | 0.070 | 0.071 | 0.029 |
Comorbidities: 1 | 0.309 | −0.134 | 0.330 | 0.333 | 0.129 | −0.154 | 0.557 | 0.558 | 0.334 | −0.161 | 0.644 | 0.645 | 0.442 |
Comorbidities: 2 | 0.335 | −0.111 | 0.384 | 0.386 | 0.163 | −0.127 | 0.570 | 0.570 | 0.341 | −0.133 | 0.643 | 0.644 | 0.431 |
Clinicians’ sex: female | 0.337 | −0.030 | 0.020 | 0.020 | 0.002 | −0.050 | 0.027 | 0.019 | 0.002 | −0.080 | 0.016 | 0.018 | 0.003 |
Clinicians’ cadre: MOd | 0.038 | 0.062 | 0.155 | 0.156 | 0.028 | 0.071 | 0.054 | 0.055 | 0.008 | 0.074 | 0.014 | 0.016 | 0.006 |
Hospital workload: low | −0.367 | −0.063 | 0.147 | 0.150 | 0.025 | −0.072 | 0.250 | 0.252 | 0.068 | −0.075 | 0.290 | 0.292 | 0.090 |
Malaria prevalence: low | −0.189 | 0.159 | 0.306 | 0.302 | 0.119 | 0.183 | 0.170 | 0.171 | 0.063 | 0.191 | 0.275 | 0.276 | 0.112 |
Enhanced A&Fe | −0.002 | −0.065 | 0.192 | 0.193 | 0.041 | −0.053 | 0.189 | 0.190 | 0.038 | −0.060 | 0.180 | 0.182 | 0.036 |
Time (months) | −1.754 | 0.015 | 0.720 | 0.721 | 0.518 | 0.017 | 0.696 | 0.698 | 0.484 | 0.018 | 0.686 | 0.687 | 0.470 |
Time× Enhanced A&F | 0.226 | −0.028 | 0.160 | 0.163 | 0.026 | −0.032 | 0.106 | 0.108 | 0.012 | −0.034 | 0.126 | 0.126 | 0.017 |
True estimate.
Empirical standard error.
Mean square error.
Medical Officer.
Audit and feedback.